Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-11
DOI
10.1038/s41598-021-89480-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis
- (2020) Joshua Griffiths et al. BMJ Open
- Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument
- (2018) Dorothee Oberdhan et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells
- (2018) Annarita Di Mise et al. Scientific Reports
- Cinacalcet versus Placebo for secondary hyperparathyroidism in chronic kidney disease patients: a meta-analysis of randomized controlled trials and trial sequential analysis
- (2018) Guoqi Wang et al. Scientific Reports
- Effect of renal transcatheter arterial embolization on quality of life in patients with autosomal dominant polycystic kidney disease
- (2017) Tatsuya Suwabe et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
- (2017) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease
- (2017) Hyunjin Ryu et al. BMC Nephrology
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
- (2017) Kidney International Supplements
- Localization and function of the renal calcium-sensing receptor
- (2016) Daniela Riccardi et al. Nature Reviews Nephrology
- The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial
- (2015) Satoru Muto et al. Clinical and Experimental Nephrology
- Volume regression of native polycystic kidneys after renal transplantation
- (2015) Yeonsoon Jung et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease
- (2015) Hyunsuk Kim et al. PLoS One
- Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease
- (2014) Edwin M. Spithoven et al. KIDNEY INTERNATIONAL
- Clinical Experiences of Bixalomer Usage at Our Hospital
- (2014) Hideaki Shima et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Polycystic liver disease: ductal plate malformation and the primary cilium
- (2014) Edgar S. Wills et al. TRENDS IN MOLECULAR MEDICINE
- A simple method to estimate renal volume from computed tomography
- (2013) Rodney H. Breau et al. CUAJ-Canadian Urological Association Journal
- Strategies Targeting cAMP Signaling in the Treatment of Polycystic Kidney Disease
- (2013) V. E. Torres et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH
- (2013) A. Maeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
- (2012) Katharina Hopp et al. JOURNAL OF CLINICAL INVESTIGATION
- Comprehensive Comparative Study of Computed Tomography–Based Estimates of Split Renal Function for Potential Renal Donors
- (2012) Shigeyoshi Soga et al. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calcium-sensing receptor and calcium kidney stones
- (2011) Giuseppe Vezzoli et al. Journal of Translational Medicine
- Calcimimetics inhibit renal pathology in rodent nephronophthisis
- (2011) Neal X. Chen et al. KIDNEY INTERNATIONAL
- Imaging Approaches to Patients With Polycystic Kidney Disease
- (2011) Arlene B. Chapman et al. SEMINARS IN NEPHROLOGY
- Calcimimetic Inhibits Late-Stage Cyst Growth in ADPKD
- (2009) V. H. Gattone et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Clinical Practice Guideline for the Management of Secondary Hyperparathyroidism in Chronic Dialysis Patients
- (2009) THERAPEUTIC APHERESIS AND DIALYSIS
- A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5′ end of Pkd1
- (2008) P.G. Starremans et al. KIDNEY INTERNATIONAL
- Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients
- (2008) R. de Mutsert et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease
- (2008) X. Wang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Autosomal Dominant Polycystic Kidney Disease
- (2008) Jared J. Grantham NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started